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Novel Biomarker of Metastatic Bladder
Cancer
Bladder cancer commonly metastasizes to both the lung
and liver. To examine the mechanisms that regulate gen-
eral or organ-specific metastasis in bladder cancer,
Smith et al (Am J Pathol 2009, 174:371–379) repeatedly
injected a bladder cancer cell line into either mouse
spleen or tail vein to generate liver- or lung-specific met-
astatic cells, respectively. On cross-site injection, these
conditioned cells continued to metastasize in an organ-
specific manner. Laminin V gamma 2 (LAMC2) was
shown to be up-regulated in both lung- and liver-specific
cell lines, as well as in human tumors. In a panel of human
bladder cancer tissues, LAMC2 levels were found to
increase as a function of tumor stage; however, LAMC2
levels were inversely correlated with lymph nodal metas-
tasis. Therefore, LAMC2 may be a novel biomarker for
bladder cancer metastasis with hematogenous, but not
lymphatic, dissemination.
Bone Marrow-Derived Collagen-Producing
Cells in Airway Remodeling
Asthmatic airway remodeling is characterized by struc-
tural changes in the lungs such as an increase in smooth
muscle mass and subendothelial fibrosis. Bone marrow-
derived fibroblasts may participate in this process, as
may stem cell factor, a growth and migratory factor that
increases airway hyperreactivity. Dolgachev et al (Am J
Pathol, 2009 174:390–400) hypothesized that stem cell
factor was involved in the recruitment and differentiation
of bone marrow-derived fibroblast precursors in a murine
model of asthma. The number of bone marrow-derived
fibroblasts significantly increased in mouse lungs after
disease induction. These cells expressed the precursor
molecules c-kit, CD31 receptor, and telomerase reverse
transcriptase. Stem cell factor neutralization not only pre-
vented airway remodeling, but also inhibited the migra-
tion of bone marrow-derived fibroblasts to the lung.
These results suggest that stem cell factor plays a key
role in recruiting bone marrow-derived fibroblasts to the
lung during the process of airway remodeling.
Staphylococcus aureus -Toxin Causes Lung
Injury
Pneumonia caused by Staphylococcus aureus is charac-
terized by severe inflammation and exaggerated neutro-
phil immigration, resulting in lung injury. To identify the
mechanisms governing this extreme immune response,
Hayashida et al (Am J Pathol 2009, 174:509–518) exam-
ined the role of S. aureus -toxin in the induction of lung
injury in mice. Mice infected with -toxin-deficient
S. aureus exhibited attenuated lung injury, as determined
by levels of neutrophil migration, vascular leakage into
lung tissue, and protein exudation into the airway, com-
pared with mice infected with wild-type S. aureus. In
addition, S. aureus -toxin induced lung injury in wild-type
but not neutropenic mice or mice that lack sphingomy-
elinase activity. The authors also examined the role of
syndecan-1, a heparin sulfate proteoglycan expressed
on alveolar epithelial cells that when shed facilitates neu-
trophil migration into lung tissue. Syndecan-1-deficient
mice were also protected from -toxin-induced lung in-
jury. These results indicate that S. aureus -toxin may
play a critical role in S. aureus-induced lung injury
through both sphingomyelinase activity and downstream
effects on syndecan-1.
Rosiglitazone Attenuates Murine Scleroderma
Scleroderma, or systemic sclerosis, results from exces-
sive collagen accumulation in the skin. Transforming
growth factor- (TGF-), an anti-inflammatory molecule,
is a key mediator of this process; however, systemic
inhibition of TGF- may result in spontaneous autoimmu-
nity. Because peroxisome proliferator activated recep-
tor- (PPAR-) has been implicated in the fibrotic pro-
cess, Wu et al (Am J Pathol 2009, 174:519–533) treated
mice that had bleomycin-induced skin inflammation with
Rosiglitazone, a potent PPAR- agonist. Rosiglitazone-
treated mice had lower levels of skin inflammation, re-
duced up-regulation of collagen expression, and fewer
myofibroblasts than control bleomycin-induced mice.
Rosiglitazone blocked TGF--mediated fibroblast activa-
tion and restored innate PPAR- expression, which is
decreased by TGF- signaling. These results implicate
PPAR- ligands as putative therapeutic agents for
scleroderma.
Loss of Glycinergic Innervation in Amyotropic
Lateral Sclerosis (ALS) Mice
Transgenic mice overexpressing mutated human SOD1
(G93A-SOD1), a Cu/Zn superoxide dismutase, provide a
model for amyotrophic lateral sclerosis, a neurological
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disease characterized by loss of motoneurons in hu-
mans. Motoneuron hyperexcitability, which leads to exci-
totoxicity, may be caused by either excessive synaptic
excitation or insufficient synaptic inhibition. Chang and
Martin (Am J Pathol 2009, 174:574–585) hypothesized
that inhibitory innervation of spinal motoneurons is abnor-
mal in G93A-SOD1 mice. Glycinergic, but not GABAergic
or cholinergic, terminals were reduced in G91A-SOD1
mice, as determined by quantitative confocal micros-
copy. This loss of inhibitory innervation preceded struc-
tural evidence for motoneuron degeneration. Therefore,
loss of inhibitory glycinergic innervation may contribute to
motoneuron hyperexcitability and degeneration in amyo-
trophic lateral sclerosis.
Constitutive Lactation and Mammary Tumor
Prevention
Extended lactation protects against human mammary
tumor development. Sotgia et al (Am J Pathol 2009,
174:613–629) demonstrated that mice deficient in
caveolin-3, which is expressed in mammary myoepi-
thelial cells, had a constitutive lactation phenotype.
Caveolin-3-deficient mammary glands underwent
lobulo-alveolar hyperplasia, similar to that observed
during pregnancy/lactation, and expressed gene tran-
scripts associated with lactation, as determined by
genome-wide transcription profiling. Specifically, three
transcription factors that regulate lactation in the mam-
mary gland, Elf5, Stat5a, and c-Myc, were up-regu-
lated in caveolin-3-deficient mice. In addition, -casein
and whey acidic protein were expressed in mammary
glands in these mice, indicating milk production. No-
tably, caveolin-3-deficient mice were also protected
against mammary tumor formation and lung metasta-
sis. These mice, therefore, represent a model of con-
stitutive lactation that may be useful in studying the
prevention or treatment of human breast cancers, and
caveolin-3 may represent a specific new therapeutic
target.
356 This Month in AJP
AJP February 2009, Vol. 174, No. 2
